🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on communication apps, based on new investigations.

Experimental Drug Gaining Traction Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are urged to message these accounts directly for supplier links, while also receiving discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and assertions of rapid British shipping. Vendors promote the drug there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Express Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in users injecting substances of unknown origin.

Several professionals stated the demand for retatrutide could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.

Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Reaction and Material Elimination

According to the social media company, the service has taken down violative material and banned related keywords and search suggestions. The organization said it was committed to maintaining the platform secure and investing in strengthening compliance measures.

Online Trading Activities

Investigations also discovered communities with up to 9,000 participants selling the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with numerous of members, populated with photos of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at home.

After minutes of entering one group, a vendor shared contact information, where most purchases occur. The seller provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about body mass, health issues or previous experience.

Item Details and Pricing

Inside these communities, posts display black plastic parcels with Royal Mail labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When asked how long a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service stated it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they cannot confirm. Even if the research behind retatrutide is valid, these online products may not include what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.

Her team has already seen individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to potentially significant health risks”.